Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice

R Phillips Campbell1, J Kintner, J Whittimore

  • 1Department of Biomedical Sciences, East Tennessee State University, Quillen College of Medicine, Johnson City, TN 37614, USA.

Microbes and Infection
|September 5, 2012
PubMed

Insights

Chlamydia muridarum exposed to amoxicillin in mice entered a viable but non-infectious persistent state. This study establishes a new animal model for studying chlamydial persistence in vivo.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pathogenesis

Background:

  • Chlamydiae can enter a persistent state in vitro when exposed to stressors like penicillin.
  • Persistent chlamydiae are viable but non-infectious, capable of resuming normal development upon stressor removal.
  • The existence and role of persistent chlamydiae in vivo remain largely undefined.

Purpose of the Study:

  • To establish an experimentally tractable in vivo model of chlamydial persistence.
  • To investigate the effects of amoxicillin treatment on Chlamydia muridarum in a mouse model.
  • To determine if chlamydial persistence can be induced in vivo.

Main Methods:

  • Female mice were vaginally infected with Chlamydia muridarum.
  • Mice were treated with amoxicillin (amox) or water.
  • Vaginal shedding was quantified, and uterine tissue was analyzed by transmission electron microscopy (TEM).
  • Chlamydial viability was assessed by pre-16s rRNA quantification.

Main Results:

  • Amoxicillin treatment reduced vaginal shedding by over 99% but did not alter pre-16s rRNA levels, indicating viability.
  • TEM revealed aberrant reticulate bodies (RB) in amoxicillin-treated mice, unlike the normal RB in controls.
  • These findings suggest amoxicillin induced a persistent state in Chlamydia muridarum in vivo.

Conclusions:

  • Amoxicillin treatment successfully induced a persistent state in Chlamydia muridarum in vivo.
  • This study presents the first experimentally tractable animal model for chlamydial persistence.
  • The developed model provides a platform for further research into the pathogenesis and treatment of chlamydial infections.